ES8104243A1 - Un procedimiento para la preparacion de derivados de imida- zolidina - Google Patents

Un procedimiento para la preparacion de derivados de imida- zolidina

Info

Publication number
ES8104243A1
ES8104243A1 ES490799A ES490799A ES8104243A1 ES 8104243 A1 ES8104243 A1 ES 8104243A1 ES 490799 A ES490799 A ES 490799A ES 490799 A ES490799 A ES 490799A ES 8104243 A1 ES8104243 A1 ES 8104243A1
Authority
ES
Spain
Prior art keywords
compound
formula
imidazole derivatives
preparing imidazole
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES490799A
Other languages
English (en)
Spanish (es)
Other versions
ES490799A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of ES490799A0 publication Critical patent/ES490799A0/es
Publication of ES8104243A1 publication Critical patent/ES8104243A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/88Nitrogen atoms, e.g. allantoin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/30Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by halogen atoms, or by nitro or nitroso groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72Two oxygen atoms, e.g. hydantoin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72Two oxygen atoms, e.g. hydantoin
    • C07D233/80Two oxygen atoms, e.g. hydantoin with hetero atoms or acyl radicals directly attached to ring nitrogen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Epoxy Resins (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pyrrole Compounds (AREA)
ES490799A 1979-04-24 1980-04-23 Un procedimiento para la preparacion de derivados de imida- zolidina Expired ES8104243A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH383779 1979-04-24

Publications (2)

Publication Number Publication Date
ES490799A0 ES490799A0 (es) 1981-04-16
ES8104243A1 true ES8104243A1 (es) 1981-04-16

Family

ID=4264536

Family Applications (1)

Application Number Title Priority Date Filing Date
ES490799A Expired ES8104243A1 (es) 1979-04-24 1980-04-23 Un procedimiento para la preparacion de derivados de imida- zolidina

Country Status (13)

Country Link
EP (1) EP0017976B1 (https=)
JP (1) JPS55143974A (https=)
KR (1) KR850000719B1 (https=)
AT (1) ATE3860T1 (https=)
CA (1) CA1135706A (https=)
DE (1) DE3063837D1 (https=)
DK (1) DK174480A (https=)
ES (1) ES8104243A1 (https=)
FI (1) FI801184A7 (https=)
GR (1) GR67605B (https=)
HU (1) HU184271B (https=)
NO (1) NO801182L (https=)
PT (1) PT71135B (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5411981A (en) * 1991-01-09 1995-05-02 Roussel Uclaf Phenylimidazolidines having antiandrogenic activity
USRE35956E (en) * 1991-01-09 1998-11-10 Roussel Uclaf Phenylimidazolidines having antiandrogenic activity
FR2724169B1 (fr) * 1994-09-06 1997-01-03 Roussel Uclaf Nouvelles phenylimidazolidines eventuellement substituees, leur procede et des intermediaires de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant
FR2715402B1 (fr) * 1994-01-05 1996-10-04 Roussel Uclaf Nouvelles phénylimidazolines éventuellement substituées, leur procédé et des intermédiaires de préparation, leur application comme médicaments et les compositions pharmaceutiques les renfermant.
TW521073B (en) * 1994-01-05 2003-02-21 Hoechst Marion Roussel Inc New optionally substituted phenylimidazolidines, their preparation process, their use as anti-androgenic agent and the pharmaceutical compositions containing them
AU2004305075A1 (en) 2003-12-19 2005-07-07 The Regents Of The University Of California Methods and materials for assessing prostate cancer therapies
NZ550102A (en) 2004-02-24 2010-10-29 Univ California Methods and materials for assessing prostate cancer therapies and compounds (thiohydantoine derivatives)
US7709517B2 (en) 2005-05-13 2010-05-04 The Regents Of The University Of California Diarylhydantoin compounds
LT2656842T (lt) 2006-03-27 2016-09-26 The Regents Of The University Of California Androgeno receptoriaus moduliatorius, skirtas prostatos vėžio ir su androgeno receptoriumi susijusių ligų gydymui
KR101456722B1 (ko) 2006-03-29 2014-10-31 더 리전트 오브 더 유니버시티 오브 캘리포니아 디아릴티오히단토인 화합물
TWI469971B (zh) 2007-10-26 2015-01-21 Univ California 二芳基乙內醯脲類化合物
WO2011103202A2 (en) 2010-02-16 2011-08-25 Aragon Pharmaceuticals, Inc. Androgen receptor modulators and uses thereof
SG11201501870RA (en) 2012-09-26 2015-04-29 Aragon Pharmaceuticals Inc Anti-androgens for the treatment of non-metastatic castrate-resistant prostate cancer
SG10201907684PA (en) 2013-01-15 2019-10-30 Aragon Pharmaceuticals Inc Androgen receptor modulator and uses thereof
TWI726969B (zh) 2016-01-11 2021-05-11 比利時商健生藥品公司 用作雄性激素受體拮抗劑之經取代之硫尿囊素衍生物
AU2018351714A1 (en) 2017-10-16 2020-04-30 Aragon Pharmaceuticals, Inc. Anti-androgens for the treatment of non-metastatic castration-resistant prostate cancer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB997037A (en) * 1962-03-19 1965-06-30 Ici Ltd New hydrantoin derivatives
US3340070A (en) * 1963-08-23 1967-09-05 Shell Oil Co Artificial sweetening agent
FR2329276A1 (fr) * 1975-10-29 1977-05-27 Roussel Uclaf Nouvelles imidazolidines substituees, procede de preparation, application comme medicament et compositions les renfermant
MC1220A1 (fr) * 1977-10-28 1979-07-20 Hoffmann La Roche Nouveaux derives d'imidazolidine
IL55774A (en) * 1977-10-28 1982-04-30 Sparamedica Ag Pharmaceutical compositions containing urea derivatives,certain such novel derivatives and their manufacture

Also Published As

Publication number Publication date
EP0017976A2 (de) 1980-10-29
PT71135A (en) 1980-05-01
DK174480A (da) 1980-10-25
GR67605B (https=) 1981-08-31
EP0017976B1 (de) 1983-06-22
CA1135706A (en) 1982-11-16
JPS55143974A (en) 1980-11-10
KR830002722A (ko) 1983-05-30
HU184271B (en) 1984-07-30
KR850000719B1 (ko) 1985-05-23
ATE3860T1 (de) 1983-07-15
ES490799A0 (es) 1981-04-16
NO801182L (no) 1980-10-27
FI801184A7 (fi) 1981-01-01
PT71135B (en) 1981-08-07
EP0017976A3 (en) 1981-04-01
DE3063837D1 (en) 1983-07-28

Similar Documents

Publication Publication Date Title
ES8104243A1 (es) Un procedimiento para la preparacion de derivados de imida- zolidina
ES8301981A1 (es) Procedimiento de preparar compuestos benzoheterociclicos.
ES8203076A1 (es) Procedimiento para preparar derivados de guanidina.
JPS57175188A (en) 2-aryl-2,1-h-azoyl(alkyl)-gamma-butyllactones
GB1489803A (en) Aminoacetamides and a process for their preparation
GB1029228A (en) A method of preparing new quaternary ammonium salts with disinfectant activity
KR840000530A (ko) 신규 벤조트리아졸의 제조방법
HUT37116A (en) Process for production of phenil-alanin derivatives
ES317157A1 (es) Un metodo de preparar un compuesto derivado de los acidos fenoxiacetico y feniltioacetico.
RO87039B1 (ro) Procedeu pentru prepararea unor derivati de acid penicilanic
BR8603787A (pt) Compostos heterociclicos,e,processo de sua preparacao e aplicacao
ES8304920A1 (es) Un procedimiento para preparar derivados de n-acil-n-hidroxi-a minoacidos.
GB1422216A (en) Phenyl-formamidine derivatives
GB1505020A (en) Substituted 2-phenylimino-thiazolines a process for their preparation and their use as ectoparasiticides
DE69001852D1 (de) Herstellung von derivaten der glutarsaeure.
ES8300733A1 (es) Un procedimiento para la preparacion de ranitidina.
MY105374A (en) A process for the preparation of 7-amino-3-methoxymeth- yl-ceph-3-em-4-carboxylic acid.
GB1085083A (en) Improvements in or relating to benzimidazoles and the manufacture thereof
SE7507318L (sv) Forfarande for framstellning av aromatiska uretaner.
GB1423017A (en) Phosphorothionoamidate derivatives having plant growth regulating properties
ES430903A1 (es) Un procedimiento para la preparacion del acido (1-oxo-2-fe- nil, halofenil o tienil-2-metil-6, 7-dicloro-5-indaniloxi) acetico.
GB1301996A (https=)
ES411420A1 (es) Procedimiento para la produccion de derivados de difenil eter.
ATE64381T1 (de) Verfahren zur herstellung von betalactamderivaten.
GB1089321A (en) Preparation of pyrazinamidoguanidines